Inventor profile of:

Carl Lebel

City:

Malibu, California

Country:

United States

Published Applications:

57

Last publication date:

2024-10-31

Top Assignees for applications by Carl Lebel

The entities that hold a legal rights for patent applications filed by inventor Lebel Carl:

Recent patent applications by Lebel Carl

Carl Lebel from Malibu, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-10-31
US20240358634A1
Human necessities

AURIS FORMULATIONS FOR TREATING OTIC DISEASES AND CONDITIONS

#2 | 2022-02-10
US20220040096A1
Human necessities

AURIS FORMULATIONS FOR TREATING OTIC DISEASES AND CONDITIONS

#3 | 2022-02-10
US20220040095A1
Human necessities

Auris formulations for treating otic diseases and conditions

#4 | 2021-12-23
US20210393511A1
Human necessities

OTIC GEL FORMULATIONS FOR TREATING OTITIS EXTERNA

#5 | 2021-07-22
US20210220263A1
Human necessities

CONTROLLED-RELEASE CNS MODULATING COMPOSITIONS AND METHODS FOR THE TREATMENT OF OTIC DISORDERS

#6 | 2020-07-23
US20200230051A1
Human necessities

Auris formulations for treating otic diseases and conditions

#7 | 2019-11-21
US20190350845A1
Human necessities

Controlled-release CNS modulating compositions and methods for the treatment of otic disorders

#8 | 2019-10-10
US20190307678A1
Human necessities

Auris formulations for treating OTIC diseases and conditions

#9 | 2019-10-03
US20190298799A1
Human necessities

CONTROLLED-RELEASE APOPTOSIS MODULATING COMPOSITIONS AND METHODS FOR THE TREATMENT OF OTIC DISORDERS

#10 | 2019-06-27
US20190192425A1
Human necessities

CONTROLLED RELEASE DELIVERY DEVICES FOR THE TREATMENT OF OTIC DISORDERS

#11 | 2018-06-14
US20180161271A1
Human necessities

Controlled release antimicrobial compositions and methods for the treatment of otic disorders

#12 | 2018-04-26
US20180110727A1
Human necessities

CONTROLLED RELEASE CORTICOSTEROID COMPOSITIONS AND METHODS FOR THE TREATMENT OF OTIC DISORDERS

#13 | 2018-03-29
US20180085304A1
Human necessities

Otic gel formulations for treating otitis externa

#14 | 2017-08-03
US20170216439A1
Human necessities

OTIC FORMULATIONS FOR THE TREATMENT OF CERUMINOSIS

#15 | 2017-02-02
US20170027930A1
Human necessities

METHODS FOR THE TREATMENT OF PEDIATRIC OTIC DISORDERS

#16 | 2017-01-05
US20170000728A1
Human necessities

Controlled-Release CNS Modulating Compositions and Methods for the Treatment of Otic Disorders

#17 | 2016-10-27
US20160310415A1
Human necessities

CONTROLLED RELEASE COMPOSITIONS FOR MODULATING FREE-RADICAL INDUCED DAMAGE AND METHODS OF USE THEREOF

#18 | 2016-08-25
US20160243028A1
Human necessities

Auris formulations for treating otic diseases and conditions

#19 | 2016-08-11
US20160228357A1
Human necessities

Auris Formulations for Treating Otic Diseases and Conditions

#20 | 2016-07-14
US20160199446A1
Human necessities

CONTROLLED-RELEASE APOPTOSIS MODULATING COMPOSITIONS AND METHODS FOR THE TREATMENT OF OTIC DISORDERS

#21 | 2016-04-07
US20160095902A1
Human necessities

Auris formulations for treating otic diseases and conditions

#22 | 2016-03-10
US20160067179A1
Human necessities

Controlled release antimicrobial compositions and methods for the treatment of otic disorders

#23 | 2016-02-25
US20160051547A1
Human necessities

Controlled release antimicrobial compositions and methods for the treatment of otic disorders

#24 | 2016-02-11
US20160038594A1
Human necessities

CONTROLLED RELEASE ANTIMICROBIAL COMPOSITIONS AND METHODS FOR THE TREATMENT OF OTIC DISORDERS

#25 | 2016-02-11
US20160038491A1
Human necessities

Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders

#26 | 2015-11-05
US20150313839A1
Human necessities

CONTROLLED RELEASE AURIS SENSORY CELL MODULATOR COMPOSITIONS AND METHODS FOR THE TREATMENT OF OTIC DISORDERS

#27 | 2015-11-05
US20150313838A1
Human necessities

Controlled release corticosteroid compositions and methods for the treatment of otic disorders

#28 | 2015-10-15
US20150290124A1
Human necessities

Methods for the treatment of pediatric otic disorders

#29 | 2015-06-04
US20150150793A1
Human necessities

Controlled release antimicrobial compositions and methods for the treatment of otic disorders

#30 | 2014-12-11
US20140364510A1
Human necessities

Controlled release aural pressure modulator compositions and methods for the treatment of OTIC disorders

#31 | 2014-12-11
US20140364403A1
Human necessities

Controlled release corticosteroid compositions and methods for the treatment of otic disorders

#32 | 2014-10-16
US20140309217A1
Human necessities

Controlled-release CNS modulating compositions and methods for the treatment of otic disorders

#33 | 2014-08-28
US20140243425A1
Human necessities

Controlled release compositions for modulating free-radical induced damage and methods of use thereof

#34 | 2014-01-16
US20140018395A1
Human necessities

Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders

#35 | 2013-08-22
US20130216609A1
Human necessities

Controlled release antimicrobial compositions and methods for the treatment of otic disorders

#36 | 2013-06-13
US20130150410A1
Human necessities

Controlled Release Ion Channel Modulator Compositions and Methods for the Treatment of Otic Disorders

#37 | 2013-05-09
US20130116210A1
Human necessities

Controlled release antimicrobial compositions and methods for the treatment of OTIC disorders

#38 | 2013-02-21
US20130045957A1
Human necessities

Prevention of and Recovery from Drug-Induced Ototoxicity

#39 | 2012-07-26
US20120190671A1
Human necessities

Controlled-release CNS modulating compositions and methods for the treatment of otic disorders

#40 | 2011-12-29
US20110319377A1
Human necessities

Controlled release corticosteroid compositions and methods for the treatment of otic disorders

#41 | 2011-12-29
US20110319375A1
Human necessities

Controlled release corticosteroid compositions and methods for the treatment of otic disorders

#42 | 2011-12-29
US20110319374A1
Human necessities

Controlled release corticosteroid compositions and methods for the treatment of otic disorders

#43 | 2011-12-29
US20110319373A1
Human necessities

Controlled release corticosteroid compositions and methods for the treatment of otic disorders

#44 | 2010-10-28
US20100273864A1
Human necessities

Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders

#45 | 2010-02-11
US20100036000A1
Human necessities

Controlled release antimicrobial compositions and methods for the treatment of otic disorders

#46 | 2010-01-28
US20100022661A1
Human necessities

Controlled release compositions for modulating free-radical induced damage and methods of use thereof

#47 | 2010-01-28
US20100021416A1
Human necessities

Controlled-release otic structure modulating and innate immune system modulating compositions and methods for the treatment of otic disorders

#48 | 2010-01-21
US20100016450A1
Human necessities

CONTROLLED RELEASE DELIVERY DEVICES FOR THE TREATMENT OF OTIC DISORDERS

#49 | 2010-01-21
US20100016218A1
Human necessities

CONTROLLED-RELEASE APOPTOSIS MODULATING COMPOSITIONS AND METHODS FOR THE TREATMENT OF OTIC DISORDERS

#50 | 2010-01-21
US20100015263A1
Human necessities

Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders

#51 | 2010-01-21
US20100015228A1
Human necessities

Controlled release ion channel modulator compositions and methods for the treatment of otic disorders

#52 | 2010-01-14
US20100009952A1
Human necessities

Controlled release corticosteroid compositions and methods for the treatment of OTIC disorders

#53 | 2010-01-07
US20100004225A1
Human necessities

Controlled release aural pressure modulator compositions and methods for the treatment of OTIC disorders

#54 | 2009-12-31
US20090325938A1
Human necessities

CONTROLLED-RELEASE CNS MODULATING COMPOSITIONS AND METHODS FOR THE TREATMENT OF OTIC DISORDERS

#55 | 2009-12-31
US20090324552A1
Human necessities

Controlled release cytotoxic agent compositions and methods for the treatment of otic disorders

#56 | 2009-12-10
US20090306225A1
Human necessities

Auris formulations for treating otic diseases and conditions

#57 | 2009-12-03
US20090297533A1
Chemistry; metallurgy

Controlled release immunomodulator compositions and methods for the treatment of otic disorders

InventorID:

102115 ⎘